ePrivacy and GPDR Cookie Consent by TermsFeed Generator

XELJANZ

11MG TBL PRO 91

SÚKL code 0238764
Name of the product XELJANZ
_MA_MEDICATION_DETAIL_INFO_MED_NAME i XELJANZ
Supplement 11MG TBL PRO 91
Strenght 11MG
Pharmaceutical form Prolonged-release tablet
Package 91
Route Oral use
Wrap type Blister
Legal status na lékařský předpis
Active substance TOFACITINIB CITRATE (TOFACITINIBI CITRAS)
ATC group L04AA29
ATC group name TOFACITINIB

Marketing authorisation information

Registration Number EU/1/17/1178/013
Type of MA centralised without orphans
MA status R - active MA/authorised medicinal product
MA Holder Pfizer Europe MA EEIG, Bruxelles
MA Holder country BELGIE

Back to list